| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $26.6M | -51.0% |
| Cost of Revenue | $20.1M | +33.9% |
| R&D Expense | $15.0M | -13.6% |
| SG&A Expense | $51.3M | -12.6% |
| Operating Income | -$61.3M | -59.8% |
| Pre-tax Income | -$91.7M | -58.4% |
| Income Tax | $3K | — |
| Net Income | -$91.7M | -58.4% |
| EPS (Basic) | -$3.59 | -36.0% |
| EPS (Diluted) | -$3.59 | -36.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.2M | +736.7% |
| Accounts Receivable | $4.7M | -65.7% |
| Inventory | $571K | -89.4% |
| Current Assets | $12.3M | -40.1% |
| Total Assets | $107.3M | -19.1% |
| Current Liabilities | $80.8M | +50.4% |
| Long-term Debt | $33.8M | — |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.3M | -107.1% |
| Capital Expenditures | $161K | +0.0% |
| Investing Cash Flow | $514K | +0.0% |
| Financing Cash Flow | $18.6M | +178.3% |
| Free Cash Flow | -$13.4M | -104.4% |
| $145.4M |
| +17.4% |
| Stockholders' Equity | -$38.1M | -530.7% |